TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF OSTEOARTHRITIS AMONG THE GERIATRIC POPULATION
4.2.2 INCREASED INCIDENCES OF BONE FRACTURES
4.2.3 TECHNOLOGICAL ADVANCEMENTS IN ENDOPROSTHESIS DEVICES ENABLING EFFECTIVE TREATMENT
4.2.4 GROWING AWARENESS AMONG POPULATION
4.3 RESTRAINTS
4.3.1 ADVERSE EFFECTS ASSOCIATED WITH ENDOPROSTHESIS POST SURGERY
4.3.2 LACK OF HEALTHCARE INFRASTRUCTURE AND UNAFFORDABILITY IN EMERGING COUNTRIES
4.3.3 RESTRAINT IMPACT ANALYSIS
4.4 OPPORTUNITIES
4.4.1 RISING R&D INVESTMENTS FOR ENDOPROSTHESIS
4.4.2 INCREASING NUMBER OF PRODUCT LAUNCH, MERGER & ACQUISITION, AND EXPANSION
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE ENDOPROSTHESIS MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON SUPPLY CHAIN
5.3.3 IMPACT ON MARKET
5.3.4 DEMAND-SUPPLY GAP ANALYSIS
6 GLOBAL ENDOPROSTHESIS MARKET BY PRODUCT
6.1 OVERVIEW
6.2 KNEE
6.3 HIP
6.4 SHOULDER
6.5 ELBOW
6.6 FINGER/HAND
6.7 ANKLE/FOOT
7 GLOBAL ENDOPROSTHESIS MARKET BY KNEE
7.1 OVERVIEW
7.2 PRIMARY KNEE REPLACEMENT
7.2.1 PRIMARY CEMENTED KNEE REPLACEMENT
7.2.2 PRIMARY CEMENTLESS KNEE REPLACEMENT
7.2.3 PRIMARY HYBRID KNEE REPLACEMENT
7.2.4 BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT
7.2.4.1 PATELLA RESURFACING
7.2.4.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT
7.2.4.3 UNCOATED KNEE REPLACEMENT
7.2.4.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)
7.2.5 MOBILE-BEARING
7.2.6 FIXED-BEARING
7.2.6.1 FIXED-BEARING WITH CEMENTED STEM
7.2.6.2 OTHERS
7.2.7 POSTERIOR STABILIZED
7.2.8 CRUCIATE-RETAINING
7.2.8.1 ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING
7.2.8.2 LATERAL PIVOT
7.2.8.3 MEDIAL PIVOT
7.3 PARTIAL KNEE REPLACEMENT
7.3.1 UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT
7.3.2 BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT
7.3.3 PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT
7.3.3.1 PATELLA RESURFACING
7.3.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT
7.3.3.3 UNCOATED KNEE REPLACEMENT
7.3.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)
7.4 REVISION KNEE REPLACEMENT
7.4.1 COMPLETE NON-HINGED REVISION KNEE REPLACEMENT
7.4.2 COMPLETE HINGED REVISION KNEE REPLACEMENT
7.4.3 PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT
7.4.3.1 PATELLA RESURFACING
7.4.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT
7.4.3.3 UNCOATED KNEE REPLACEMENT
7.4.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)
7.4.3.5 DEFECT FILLER (METAPHYSEAL)
7.5 TUMOR
7.5.1 PROXIMAL TIBIA REPLACEMENT
7.5.2 DISTAL FEMUR REPLACEMENT
7.6 CUSTOM MADE REPLACEMENT
7.6.1 GROWING PROSTHESIS
8 GLOBAL ENDOPROSTHESIS MARKET BY HIP
8.1 OVERVIEW
8.2 PRIMARY HIP REPLACEMENT
8.2.1 PRIMARY CEMENTED HIP REPLACEMENT
8.2.2 PRIMARY CEMENTLESS HIP REPLACEMENT
8.2.3 PRIMARY HYBRID HIP REPLACEMENT
8.2.3.1 DUAL MOBILITY CUP CEMENTED
8.2.3.2 DUAL MOBILITY CUP CEMENTLESS
8.2.4 HIP RESURFACING
8.2.5 TOTAL HIP RESURFACING
8.2.6 HEMI HIP RESURFACING
8.3 PARTIAL HIP REPLACEMENT
8.3.1 BIPOLAR PARTIAL HIP REPLACEMENT
8.3.2 UNIPOLAR PARTIAL HIP REPLACEMENT
8.3.3 ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT
8.4 CUSTOM HIP REPLACEMENTS
8.5 REVISION HIP REPLACEMENT
8.5.1 COMPLETE HIP REVISION
8.5.1.1 COMPLETE HIP REVISION WITH DUAL MOBILITY CUP
8.5.2 ACETABULAR COMPONENT REVISION
8.5.2.1 ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP
8.5.3 FEMORAL STEM REVISION
8.5.4 OTHER HIP REVISION
8.6 TUMOR
8.6.1 PROXIMAL FEMUR REPLACEMENT
9 GLOBAL ENDOPROSTHESIS MARKET BY SHOULDER
9.1 OVERVIEW
9.2 PRIMARY SHOULDER REPLACEMENT
9.2.1 PARTIAL SHOULDER REPLACEMENT
9.2.2 TOTAL/PRIMARY SHOULDER REPLACEMENT
9.2.3 REVERSE SHOULDER REPLACEMENT
9.2.4 SHOULDER RESURFACING
9.3 REVISION SHOULDER REPLACEMENTS
9.4 TUMOR
9.4.1 PROXIMAL HUMERUS REPLACEMENT
9.5 CUSTOM MADE REPLACEMENTS
10 GLOBAL ENDOPROSTHESIS MARKET BY ELBOW
10.1 OVERVIEW
10.2 TOTAL ELBOW REPLACEMENT
10.3 RADIAL HEAD REPLACEMENT
10.4 TUMOR
10.4.1 PROXIMAL ULNA REPLACEMENT
10.4.2 DISTAL HUMERUS REPLACEMENT
10.5 CUSTOM MADE REPLACEMENTS
11 GLOBAL ENDOPROSTHESIS MARKET BY FINGER/HAND
11.1 OVERVIEW
11.2 TOTAL WRIST PROTHESIS
11.3 PIP FINGER PROSTHESIS
11.4 MCP FINGER PROSTHESIS
11.4.1 CARPOMETACARPAL JOINT PROSTHESIS
11.4.2 OTHERS
12 GLOBAL ENDOPROSTHESIS MARKET BY ANKLE/FOOT
12.1 OVERVIEW
12.2 TOTAL ANKLE
12.3 GREAT TOE IMPLANT
13 GLOBAL ENDOPROSTHESIS MARKET, BY REGION
13.1 OVERVIEW
13.2 NORTH AMERICA
13.2.1 US
13.2.2 CANADA
13.2.3 MEXICO
13.3 SOUTH AMERICA
13.3.1 ARGENTINA
13.3.2 BRAZIL
13.3.3 COLOMBIA
13.3.4 PERU
13.3.5 CHILE
13.3.6 ECUADOR
13.3.7 REST OF SOUTH AMERICA
13.4 EUROPE
13.4.1 GERMANY
13.4.2 AUSTRIA
13.4.3 SWISS
13.4.4 FINLAND
13.4.5 DENMARK
13.4.6 NORWAY
13.4.7 SWEDEN
13.4.8 BELGIUM
13.4.9 FRANCE
13.4.10 NETHERLANDS
13.4.11 GREAT BRITAIN
13.4.12 CZECHIA
13.4.13 ITALIA
13.4.14 SPAIN
13.4.15 HUNGARY
13.4.16 IRELAND
13.4.17 PORTUGAL
13.4.18 POLAND
13.4.19 RUSSIA
13.4.20 ROMANIA
13.4.21 TURKEY
13.4.22 REST OF EUROPE
13.5 ASIA-PACIFIC
13.5.1 CHINA
13.5.2 JAPAN
13.5.3 INDIA
13.5.4 AUSTRALIA
13.5.5 SOUTH KOREA
13.5.6 TAIWAN
13.5.7 NEW ZEALAND
13.5.8 REST OF ASIA-PACIFIC
13.6 MIDDLE EAST & AFRICA
13.6.1 SAUDI ARABIA
13.6.2 UAE
13.6.3 EGYPT
13.6.4 ISRAEL
13.6.5 SOUTH AFRICA
13.6.6 SYRIA
13.6.7 REST OF MEA
14 COMPETITIVE LANDSCAPE
14.1 COMPETITIVEOVERVIEW
14.2 MAJOR PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET
14.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL ENDOPROSTHESIS MARKET
14.4 COMPETITIVE BENCHMARKING
14.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ENDOPROSTHESIS MARKET
14.6 KEY DEVELOPMENT ANALYSIS
14.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
14.7.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES
14.7.2 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES
14.8 MAJOR PLAYERS FINANCIAL MATRIX
14.8.1 REVENUE OF MAJOR PLAYERS
14.8.2 R&D EXPENDITURE
15 COMPANY PROFILES
15.1 JOHNSON & JOHNSON SERVICES, INC.
15.1.1 COMPANY OVERVIEW
15.1.2 FINANCIAL OVERVIEW
15.1.3 PRODUCTS/SERVICES OFFERED
15.1.4 KEY DEVELOPMENTS
15.1.5 SWOT ANALYSIS
15.1.6 KEY STRATEGIES
15.2 ZIMMER BIOMET HOLDINGS INC.
15.2.1 COMPANY OVERVIEWS
15.2.2 FINANCIAL OVERVIEW
15.2.3 PRODUCTS/SERVICES OFFERED
15.2.4 KEY DEVELOPMENTS
15.2.5 SWOT ANALYSIS
15.2.6 KEY STRATEGIES
15.3 STRYKER
15.3.1 COMPANY OVERVIEW
15.3.2 FINANCIAL OVERVIEW
15.3.3 PRODUCTS/SERVICES OFFERED
15.3.4 KEY DEVELOPMENTS
15.3.5 SWOT ANALYSIS
15.3.6 KEY STRATEGIES
15.4 SMITH AND NEPHEW
15.4.1 COMPANY OVERVIEW
15.4.2 FINANCIAL OVERVIEW
15.4.3 PRODUCTS/SERVICES OFFERED
15.4.4 KEY DEVELOPMENTS
15.4.5 SWOT ANALYSIS
15.4.6 KEY STRATEGIES
15.5 WALDEMAR LINK GMBH & CO. KG
15.5.1 COMPANY OVERVIEW
15.5.2 FINANCIAL OVERVIEW
15.5.3 PRODUCTS/SERVICES OFFERED
15.5.4 KEY DEVELOPMENTS
15.5.5 SWOT ANALYSIS
15.5.6 KEY STRATEGIES
15.6 LIMACORPORATE SPA.
15.6.1 COMPANY OVERVIEW
15.6.2 FINANCIAL OVERVIEW
15.6.3 PRODUCTS/SERVICES OFFERED
15.6.4 KEY DEVELOPMENTS
15.6.5 SWOT ANALYSIS
15.6.6 KEY STRATEGIES
15.7 CORIN LTD
15.7.1 COMPANY OVERVIEW
15.7.2 FINANCIAL OVERVIEW
15.7.3 PRODUCTS OFFERED
15.7.4 KEY DEVELOPMENTS
15.7.5 SWOT ANALYSIS
15.7.6 KEY STRATEGIES
15.8 PETER BREHM GMBH
15.8.1 COMPANY OVERVIEW
15.8.2 FINANCIAL OVERVIEW
15.8.3 PRODUCTS OFFERED
15.8.4 KEY DEVELOPMENTS
15.8.5 SWOT ANALYSIS
15.8.6 KEY STRATEGIES
15.9 MATHYS LTD BETTLACH
15.9.1 COMPANY OVERVIEW
15.9.2 FINANCIAL OVERVIEW
15.9.3 PRODUCTS OFFERED
15.9.4 KEY DEVELOPMENTS
15.9.5 SWOT ANALYSIS
15.9.6 KEY STRATEGIES
15.10 B. BRAUN MELSUNGEN AG
15.10.1 COMPANY OVERVIEW
15.10.2 FINANCIAL OVERVIEW
15.10.3 PRODUCTS OFFERED
15.10.4 KEY DEVELOPMENTS
15.10.5 SWOT ANALYSIS
15.10.6 KEY STRATEGIES
15.11 MEDACTA INTERNATIONAL SA
15.11.1 COMPANY OVERVIEW
15.11.2 FINANCIAL OVERVIEW
15.11.3 PRODUCTS/SERVICES OFFERED
15.11.4 KEY DEVELOPMENTS
15.11.5 SWOT ANALYSIS
15.11.6 KEY STRATEGIES
15.12 EXACTECH, INC.
15.12.1 COMPANY OVERVIEW
15.12.2 FINANCIAL OVERVIEW
15.12.3 PRODUCTS OFFERED
15.12.4 KEY DEVELOPMENTS
15.12.5 SWOT ANALYSIS
15.12.6 KEY STRATEGIES
15.13 MICROPORT ORTHOPEDICS, INC.
15.13.1 COMPANY OVERVIEW
15.13.2 FINANCIAL OVERVIEW
15.13.3 PRODUCTS OFFERED
15.13.4 KEY DEVELOPMENTS
15.13.5 SWOT ANALYSIS
15.13.6 KEY STRATEGIES
15.14 TIPSAN
15.14.1 COMPANY OVERVIEW
15.14.2 FINANCIAL OVERVIEW
15.14.3 PRODUCTS OFFERED
15.14.4 KEY DEVELOPMENTS
15.14.5 SWOT ANALYSIS
15.14.6 KEY STRATEGIES
15.15 BAUMER SA.
15.15.1 COMPANY OVERVIEW
15.15.2 FINANCIAL OVERVIEW
15.15.3 PRODUCTS OFFERED
15.15.4 KEY DEVELOPMENTS
15.15.5 SWOT ANALYSIS
15.15.6 KEY STRATEGIES
15.16 IMPOL
15.16.1 COMPANY OVERVIEW
15.16.2 FINANCIAL OVERVIEW
15.16.3 PRODUCTS OFFERED
15.16.4 KEY DEVELOPMENTS
15.16.5 SWOT ANALYSIS
15.16.6 KEY STRATEGIES
15.17 GROUPE LEPINE
15.17.1 COMPANY OVERVIEW
15.17.2 FINANCIAL OVERVIEW
15.17.3 PRODUCTS OFFERED
15.17.4 KEY DEVELOPMENTS
15.17.5 SWOT ANALYSIS
15.17.6 KEY STRATEGIES
15.18 CONFORMIS
15.18.1 COMPANY OVERVIEW
15.18.2 FINANCIAL OVERVIEW
15.18.3 PRODUCTS OFFERED
15.18.4 KEY DEVELOPMENTS
15.18.5 SWOT ANALYSIS
15.18.6 KEY STRATEGIES
15.19 DJO
15.19.1 COMPANY OVERVIEW
15.19.2 FINANCIAL OVERVIEW
15.19.3 PRODUCTS OFFERED
15.19.4 KEY DEVELOPMENTS
15.19.5 SWOT ANALYSIS
15.19.6 KEY STRATEGIES
15.20 IMPLANTCAST
15.20.1 COMPANY OVERVIEW
15.20.2 FINANCIAL OVERVIEW
15.20.3 PRODUCTS OFFERED
15.20.4 KEY DEVELOPMENTS
15.20.5 SWOT ANALYSIS
15.20.6 KEY STRATEGIES
16 APPENDIX
16.1 REFERENCES
16.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 4 GLOBAL: ENDOPROSTHESIS MARKET, BY KNEE, 2022–2030 (USD MILLION)
TABLE 5 GLOBAL: ENDOPROSTHESIS MARKET, BY HIP, 2022–2030 (USD MILLION)
TABLE 6 GLOBAL: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022–2030 (USD MILLION)
TABLE 7 GLOBAL: ENDOPROSTHESIS MARKET, BY ELBOW, 2022–2030 (USD MILLION)
TABLE 8 GLOBAL: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022–2030 (USD MILLION)
TABLE 9 GLOBAL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022–2030 (USD MILLION)
TABLE 10 GLOBAL: ENDOPROSTHESIS MARKET, BY KNEE TYPE, 2022-2030 (USD MILLION)
TABLE 11 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 12 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY TYPE 2022–2030 (USD MILLION)
TABLE 13 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTED KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 14 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTLESS KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 15 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 16 GLOBAL: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 17 GLOBAL: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 18 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2022–2030 (USD MILLION)
TABLE 19 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 20 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 21 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2022–2030 (USD MILLION)
TABLE 22 GLOBAL: ENDOPROSTHESIS MARKET, FOR MOBILE-BEARING, BY REGION, 2022–2030 (USD MILLION)
TABLE 23 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY REGION, 2022–2030 (USD MILLION)
TABLE 24 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022–2030 (USD MILLION)
TABLE 25 GLOBAL: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING WITH CEMENTED STEM, BY REGION, 2022–2030 (USD MILLION)
TABLE 26 GLOBAL: ENDOPROSTHESIS MARKET, BY OTHERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 27 GLOBAL: ENDOPROSTHESIS MARKET, FOR POSTERIOR STABILIZED, BY REGION, 2022–2030 (USD MILLION)
TABLE 28 GLOBAL: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY REGION, 2022–2030 (USD MILLION)
TABLE 29 GLOBAL: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022–2030 (USD MILLION)
TABLE 30 GLOBAL: ENDOPROSTHESIS MARKET, FOR ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING, BY REGION, 2022–2030 (USD MILLION)
TABLE 31 GLOBAL: ENDOPROSTHESIS MARKET, FOR LATERAL PIVOT, BY REGION, 2022–2030 (USD MILLION)
TABLE 32 GLOBAL: ENDOPROSTHESIS MARKET, FOR MEDIALPIVOT, BY REGION, 2022–2030 (USD MILLION)
TABLE 33 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 34 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY TYPE 2022–2030 (USD MILLION)
TABLE 35 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 36 GLOBAL: ENDOPROSTHESIS MARKET, FOR BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 37 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 38 GLOBAL: ENDOPROSTHESIS MARKET, BY PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 39 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2022–2030 (USD MILLION)
TABLE 40 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 41 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 42 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2022–2030 (USD MILLION)
TABLE 43 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 44 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 45 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE NON-HINGED REVISION KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 46 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HINGED REVISION KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 47 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 48 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 49 GLOBAL: ENDOPROSTHESIS MARKET, FOR PATELLA RESURFACING, BY REGION, 2022–2030 (USD MILLION)
TABLE 50 GLOBAL: ENDOPROSTHESIS MARKET, FOR COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 51 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNCOATED KNEE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 52 GLOBAL: ENDOPROSTHESIS MARKET, FOR PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E), BY REGION, 2022–2030 (USD MILLION)
TABLE 53 GLOBAL: ENDOPROSTHESIS MARKET, FOR DEFECT FILLER (METAPHYSEAL), BY REGION, 2022–2030 (USD MILLION)
TABLE 54 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2022–2030 (USD MILLION)
TABLE 55 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2022–2030 (USD MILLION)
TABLE 56 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL TIBIA REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 57 GLOBAL: ENDOPROSTHESIS MARKET, FOR DISTAL FEMUR REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 58 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 59 GLOBAL: ENDOPROSTHESIS MARKET, FOR GROWING PROSTHESIS, BY REGION, 2022–2030 (USD MILLION)
TABLE 60 GLOBAL: ENDOPROSTHESIS MARKET, BY HIP TYPE, 2022-2030 (USD MILLION)
TABLE 61 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 62 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 63 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTED HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 64 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY CEMENTLESS HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 65 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 66 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 67 GLOBAL: ENDOPROSTHESIS MARKET, FOR DUAL MOBILITY CUP CEMENTED, BY REGION, 2022–2030 (USD MILLION)
TABLE 68 GLOBAL: ENDOPROSTHESIS MARKET, FOR DUAL MOBILITY CUP CEMENTLESS, BY REGION, 2022–2030 (USD MILLION)
TABLE 69 GLOBAL: ENDOPROSTHESIS MARKET, FOR HIP RESURFACING, BY REGION, 2022–2030 (USD MILLION)
TABLE 70 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL HIP RESURFACING, BY REGION, 2022–2030 (USD MILLION)
TABLE 71 GLOBAL: ENDOPROSTHESIS MARKET, FOR HEMI HIP RESURFACING, BY REGION, 2022–2030 (USD MILLION)
TABLE 72 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 73 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 74 GLOBAL: ENDOPROSTHESIS MARKET, FOR BIPOLAR PARTIAL HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 75 GLOBAL: ENDOPROSTHESIS MARKET, FOR UNIPOLAR PARTIAL HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 76 GLOBAL: ENDOPROSTHESIS MARKET, FOR ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 77 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM HIP REPLACEMENTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 78 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 79 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 80 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 81 GLOBAL: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION WITH DUAL MOBILITY CUP, BY REGION, 2022–2030 (USD MILLION)
TABLE 82 GLOBAL: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, BY REGION, 2022–2030 (USD MILLION)
TABLE 83 GLOBAL: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP, BY REGION, 2022–2030 (USD MILLION)
TABLE 84 GLOBAL: ENDOPROSTHESIS MARKET, FOR FEMORAL STEM REVISION, BY REGION, 2022–2030 (USD MILLION)
TABLE 85 GLOBAL: ENDOPROSTHESIS MARKET, FOR OTHER HIP REVISION, BY REGION, 2022–2030 (USD MILLION)
TABLE 86 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2022–2030 (USD MILLION)
TABLE 87 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL FEMUR REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 88 GLOBAL: ENDOPROSTHESIS MARKET, BY SHOULDER TYPE, 2022-2030 (USD MILLION)
TABLE 89 GLOBAL: ENDOPROSTHESIS MARKET, BY PRIMARY SHOULDER REPLACEMENT, 2022–2030 (USD MILLION)
TABLE 90 GLOBAL: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, BY TYPE, 2022–2030 (USD MILLION)
TABLE 91 GLOBAL: ENDOPROSTHESIS MARKET, FOR PARTIAL SHOULDER REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 92 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL/PRIMARY SHOULDER REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 93 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVERSE SHOULDER REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 94 GLOBAL: ENDOPROSTHESIS MARKET, FOR SHOULDER RESURFACING, BY REGION, 2022–2030 (USD MILLION)
TABLE 95 GLOBAL: ENDOPROSTHESIS MARKET, FOR REVISION SHOULDER REPLACEMENTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 96 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2022–2030 (USD MILLION)
TABLE 97 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2022–2030 (USD MILLION)
TABLE 98 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL HUMERUS REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 99 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 100 GLOBAL: ENDOPROSTHESIS MARKET, BY ELBOW TYPE, 2022-2030 (USD MILLION)
TABLE 101 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL ELBOW REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 102 GLOBAL: ENDOPROSTHESIS MARKET, FOR RADIAL HEAD REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 103 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY REGION, 2022–2030 (USD MILLION)
TABLE 104 GLOBAL: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2022–2030 (USD MILLION)
TABLE 105 GLOBAL: ENDOPROSTHESIS MARKET, FOR PROXIMAL ULNA REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 106 GLOBAL: ENDOPROSTHESIS MARKET, FOR DISTAL HUMERUS REPLACEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 107 GLOBAL: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 108 GLOBAL: ENDOPROSTHESIS MARKET, BY FINGER/HAND TYPE, 2022-2030 (USD MILLION)
TABLE 109 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL WRIST PROTHESIS, BY REGION, 2022–2030 (USD MILLION)
TABLE 110 GLOBAL: ENDOPROSTHESIS MARKET, FOR PIP FINGER PROSTHESIS, BY REGION, 2022–2030 (USD MILLION)
TABLE 111 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY REGION, 2022–2030 (USD MILLION)
TABLE 112 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 113 GLOBAL: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, BY REGION, 2022–2030 (USD MILLION)
TABLE 114 GLOBAL: ENDOPROSTHESIS MARKET, FOR OTHERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 115 GLOBAL: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT TYPE, 2022-2030 (USD MILLION)
TABLE 116 GLOBAL: ENDOPROSTHESIS MARKET, FOR TOTAL ANKLE, BY REGION, 2022–2030 (USD MILLION)
TABLE 117 GLOBAL: ENDOPROSTHESIS MARKET, FOR GREAT TOE IMPLANT, BY REGION, 2022–2030 (USD MILLION)
TABLE 118 GLOBAL: ENDOPROSTHESIS MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 119 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 120 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 121 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRODUCT, BY KNEE, 2022-2030 (USD MILLION)
TABLE 122 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 123 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 124 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 125 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 126 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 127 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 128 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 129 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 130 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, BY TYPE, 2022-2030 (USD MILLION)
TABLE 131 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 132 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)
TABLE 133 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 134 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 135 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 136 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 137 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)
TABLE 138 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)
TABLE 139 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)
TABLE 140 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)
TABLE 141 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 142 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)
TABLE 143 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)
TABLE 144 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)
TABLE 145 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)
TABLE 146 NORTH AMERICA: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)
TABLE 147 NORTH AMERICA: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)
TABLE 148 US: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 149 US: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)
TABLE 150 US: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 151 US: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 152 US: ENDOPROSTHESIS MARKET, FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 153 US: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 154 US: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 155 US: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 156 US: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 157 US: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 158 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)
TABLE 159 US: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)
TABLE 160 US: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)
TABLE 161 US: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 162 US: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 163 US: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 164 US: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 165 US: ENDOPROSTHESIS MARKET, COMPLETE HIP REVISION, 2022-2030 (USD MILLION)
TABLE 166 US: ENDOPROSTHESIS MARKET, FOR ACETABULAR COMPONENT REVISION, 2022-2030 (USD MILLION)
TABLE 167 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)
TABLE 168 US: ENDOPROSTHESIS MARKET, BY SHOULDER, 2022-2030 (USD MILLION)
TABLE 169 US: ENDOPROSTHESIS MARKET, FOR PRIMARY SHOULDER REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 170 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)
TABLE 171 US: ENDOPROSTHESIS MARKET, BY ELBOW, 2022-2030 (USD MILLION)
TABLE 172 US: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)
TABLE 173 US: ENDOPROSTHESIS MARKET, BY FINGER/HAND, 2022-2030 (USD MILLION)
TABLE 174 US: ENDOPROSTHESIS MARKET, FOR MCP FINGER PROSTHESIS, 2022-2030 (USD MILLION)
TABLE 175 US: ENDOPROSTHESIS MARKET, BY ANKLE/FOOT, 2022-2030 (USD MILLION)
TABLE 176 CANADA: ENDOPROSTHESIS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
TABLE 177 CANADA: ENDOPROSTHESIS MARKET, BY KNEE, 2022-2030 (USD MILLION)
TABLE 178 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY KNEE REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 179 CANADA: ENDOPROSTHESIS MARKET, FOR BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 180 CANADA: ENDOPROSTHESIS MARKET, FOR FIXED-BEARING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 181 CANADA: ENDOPROSTHESIS MARKET, FOR CRUCIATE-RETAINING, BY TYPE, 2022-2030 (USD MILLION)
TABLE 182 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL KNEE REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 183 CANADA: ENDOPROSTHESIS MARKET, FOR PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 184 CANADA: ENDOPROSTHESIS MARKET, FOR REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 185 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 186 CANADA: ENDOPROSTHESIS MARKET, FOR TUMOR, 2022-2030 (USD MILLION)
TABLE 187 CANADA: ENDOPROSTHESIS MARKET, FOR CUSTOM MADE REPLACEMENTS, 2022-2030 (USD MILLION)
TABLE 188 CANADA: ENDOPROSTHESIS MARKET, BY HIP, 2022-2030 (USD MILLION)
TABLE 189 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 190 CANADA: ENDOPROSTHESIS MARKET, FOR PRIMARY HYBRID HIP REPLACEMENT, BY TYPE, 2022-2030 (USD MILLION)
TABLE 191 CANADA: ENDOPROSTHESIS MARKET, FOR PARTIAL HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 192 CANADA: ENDOPROSTHESIS MARKET, FOR REVISION HIP REPLACEMENT, 2022-2030 (USD MILLION)
TABLE 193 CANADA: ENDOPROSTHESIS MARKET, FOR COMPLETE HIP REVISION, 2022-2030 (USD MILLION)
TABLE 194 CANADA: ENDOPRO
